(Q47917455)

English

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors

scientific article published in December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Miguel A Martinez

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Bonaventura Clotet Sala

2

object named as

Clotet B

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

author name string

Cabana M

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

59

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

480-490

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Resisting resistance: maximizing the durability of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Phylogenies from molecular sequences: inference and reliability

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

HIV-1: gambling on the evolution of drug resistance?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

HIV treatment failure: testing for HIV resistance in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C480%3A%3AAID-JMV10%3E3.0.CO%3B2-8

21 January 2018

Identifiers

10.1002/(SICI)1096-9071(199912)59:4<480::AID-JMV10>3.0.CO;2-8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/10534730

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47917455&oldid=2175710790"